Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...

Sleeping on the left side can actively help the body’s glymphatic system, which is responsible for clearing out toxins from ...

RenovoRx (RNXT) highlighted its recent abstract presentation at the 2025 Society of Interventional Oncology Annual Conference in Las Vegas, ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

Insulin is a hormone produced by the pancreas ... Without an adequate insulin supply, glucose can’t enter your cells, meaning more stays in your blood. (Learn more about The Average Weight ...

Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...

Body weight and body mass index alone are not enough to predict whether someone will develop a metabolic disease. A new atlas of cells in fat tissue could help to explain why some overweight people ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Korean researchers explore fat grafting as a new cancer treatment method Innovative cancer therapy harnesses the power of beige fat grafting for enhanced treatment outcomes.

Today, Plantsulin blends this century-old discovery with modern scientific validation to offer a fast, convenient “whole-body reboot” for maintaining optimal glucose levels. Unlike restrictive diets ...